Dr. Ahmad Tarhini presents on improving efficacy of personalized vaccines to treat cancer.
The goal is to accelerate 100 FDA-approved cancer immunotherapy drugs
over the next 10 years.
Check out the recap video for a look back at Moffitt's presence at #SITC23!
Dr. Dmitry Gabrilovich
discusses advances in myeloid-derived suppressor cells for cancer.
Moffitt Celebrates
Reception honors the immunotherapy work of our investigators.
Immunotherapy Advances on Display
Moffitt investigators share their work during poster sessions.
The CheckPoints Bring the Party
SITC's band hosts annual concert
on the West Coast this year.
Dr. Joseph Markowitz
discusses melanoma research with Moffitt CEO Dr. Patrick Hwu.
Dr. Paulo Rodriguez
shares the latest immunotherapy discoveries presented at SITC.
Dr. Lilit Karapetyan presents her work on lymphoid aggregates in patients with melanoma.
FOLLOW US ON
VIEW THIS EMAIL AS A WEBPAGE
